Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: OU46IGC49F

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-13 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Asthma 2 D001249 ClinicalTrials
Colitis, Ulcerative 2 D003093 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 910649-32-0
ChEMBL CHEMBL1742985
FDA SRS OU46IGC49F